RYBELSUS N cpr 4 mg 30 pce

7680698650027 CH-69865 A10BJ06 07.06.2.

Active substances:

Semaglutidum

No images available

Details

Product number
6986502
CPT
-
Packaging group
30
Unit
Tablette(n)
Composition
semaglutidum 4 mg, natrii salcaprozas corresp. natrium 8 mg, magnesii stearas, pro compresso.

Articles (1)

Rybelsus N 4 mg, Tabletten
Tabletten
30
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
01/09/2026
Patient information leaflet
Français
01/09/2026
Patient information leaflet
Italien
01/09/2026
Professional SmPC
Allemand
01/09/2026
Professional SmPC
Français
01/09/2026
Professional SmPC
Italien
01/09/2026

Detailed composition

Substance Quantity Type Category
semaglutidum
4.0 MG Substance Wirkstoff (Principe actif)
natrii salcaprozas
- Substance HNIDK
natrium
8.0 MG Substance HBESI
magnesii stearas
- Substance HNIDK

Reimbursement information

Public price
CHF 113.50
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/04/2026

Authorization holder

Novo Nordisk Pharma AG

8302 Kloten

Authorization information

Swissmedic authorization number
69865
Drug name
Rybelsus N, Tabletten
Galenic form
TAB
ATC Code
A10BJ06
Authorization status
Z
Dispensation category
B
First authorization
28/11/2025
Authorization expiration date
27/11/2030
IT number
07.06.2.
Domain
Human medicine
Field of application
Diabetes mellitus Typ 2, Reduktion des Risikos schwerwiegender kardiovaskulärer Ereignisse

Packaging details

Description (FR)
RYBELSUS N cpr 4 mg 30 pce
Description (DE)
RYBELSUS N Tabl 4 mg 30 Stk
Market launch
01/04/2026
Narcotic (BTM)
No

Other packaging sizes

RYBELSUS N cpr 1.5 mg 30 pce
30 TABL
GTIN: 7680698650010
View
RYBELSUS N cpr 4 mg 90 pce
90 TABL
GTIN: 7680698650034
View
RYBELSUS N cpr 9 mg 30 pce
30 TABL
GTIN: 7680698650041
View
RYBELSUS N cpr 9 mg 90 pce
90 TABL
GTIN: 7680698650058
View
Buy us a coffee Explore the data